An AI Reads 149,000 Reddit Posts for Drug Side Effects

Drug safety is usually tracked through clinical trials and the paperwork doctors file when something goes wrong. A study from the University of Pennsylvania suggests a noisier source worth watching too: the places online where people compare notes about what they are actually taking. The researchers pointed a language model at Reddit and asked it to read the room.

The target was retatrutide, an experimental weight-loss drug still working through Phase 3 trials, the last stage before any decision on approval. Because it is not yet approved, a gray market has grown up around versions sold online, often labeled for research use, that the FDA warns people not to buy. Those buyers do not show up in a trial database. They do show up on Reddit.

The team analyzed roughly 149,000 posts and comments from weight-loss and peptide communities through December 2025, using a validated model to sort genuine self-reports from chatter and to pull out the symptoms people described. It identified 13,589 users who said they were currently taking the drug, and 7,823 who reported at least one effect once weight loss and appetite suppression were set aside. The work appeared first as a medRxiv preprint and, by one account, later in JAMA Network Open.

A different picture than the trials

The pattern that emerged did not match the clinical record. Fatigue led the self-reports at 15.2 percent, followed by increased energy at 12.4 percent, nausea at 11.6 percent, insomnia at 6.1 percent and a raised heart rate at 4.8 percent. The single most common individual report was increased appetite, an odd thing to hear about a drug designed to suppress it. In the formal trials, gastrointestinal complaints such as nausea and diarrhea dominate the safety tables. Among these online users, stomach trouble was common but did not run the show.

The researchers are careful about what this does and does not prove. A Reddit post cannot establish that the drug caused the symptom, and people buying unregulated vials may be taking something quite different from the trial formulation, at doses no clinician set. This is a signal, not a verdict. The value is in the early warning. A pattern that surfaces across thousands of anonymous accounts can flag a question for regulators and trial designers long before it reaches a formal report.

It is also a tidy illustration of where AI earns its keep in medicine, which is rarely the dramatic part. The interesting work is less about a model that claims to out-diagnose a doctor and more about one that can read a volume of messy human text no team could get through, and hand back something a specialist can act on. The same quiet pattern-finding is what lets AI tools estimate which cancers are likely to return. Reading 149,000 Reddit posts for a buried safety signal is not glamorous. It is exactly the sort of job worth handing to a machine.